SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-08-000030
Filing Date
2008-01-22
Accepted
2008-01-22 16:43:23
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND, II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 neurcrinebiosciences.htm SC 13G 235694
  Complete submission text file 0000898432-08-000030.txt   237883
Mailing Address 12790 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Subject) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46089 | Film No.: 08542297
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice